Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 13, 2022

SELL
$3.0 - $4.25 $86,196 - $122,111
-28,732 Closed
0 $0
Q4 2021

Feb 14, 2022

SELL
$3.85 - $6.71 $127,800 - $222,738
-33,195 Reduced 53.6%
28,732 $113,000
Q3 2021

Nov 12, 2021

SELL
$5.6 - $8.58 $353,444 - $541,526
-63,115 Reduced 50.48%
61,927 $350,000
Q2 2021

Aug 13, 2021

BUY
$7.16 - $9.41 $6,444 - $8,469
900 Added 0.72%
125,042 $1.08 Million
Q1 2021

May 14, 2021

BUY
$7.52 - $15.55 $211,552 - $437,452
28,132 Added 29.3%
124,142 $1.17 Million
Q4 2020

Feb 12, 2021

BUY
$5.0 - $8.85 $480,050 - $849,688
96,010 New
96,010 $666,000

Others Institutions Holding CRON

About Cronos Group Inc.


  • Ticker CRON
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 377,896,000
  • Market Cap $744M
  • Description
  • Cronos Group Inc. operates as a cannabinoid company. It manufactures, markets, and distributes hemp-derived supplements and cosmetic products through e-commerce, retail, and hospitality partner channels under the Lord Jones and Happy Dance brands in the United States. The company is also involved in the cultivation, manufacture, and marketing of...
More about CRON
Track Ray Dalio's Portfolio

Track Ray Dalio Portfolio

Follow Ray Dalio (Bridgewater Associates, LP) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bridgewater Associates, LP, based on Form 13F filings with the SEC.

News

Stay updated on Bridgewater Associates, LP and Ray Dalio with notifications on news.